SAN JOSE, California,Oct. 15, 2015/PRNewswire/ -- Teikoku PharmaUSAInc. ("TPU") today announced that it has entered into an exclusive license agreement with Eagle Pharmaceuticals, Inc. to market, sell, and distribute TPU's Docetaxel Injection, Non-Alcohol Formula inthe United States. Once ap...
Teikoku PharmaUSA, Inc. is located inSan Jose, California, a wholly-owned subsidiary of Teikoku Seiyaku Co., Ltd. ofJapan. This international specialty pharmaceutical company is focused on developing novel best-in-class treatment solu...